CAPR
Capricor Therapeutics Inc
8.90$
-1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.4% | -15.5% | -57.1% | +22.2% | -39.9% | -69.1% | -21.1% | +941.8% | +886.8% | -11.5% | -100.0% | |
| – | +76.7% | +16.6% | -32.9% | +12.1% | -57.4% | +64.5% | -97.1% | +8,779.6% | +67.1% | +37.1% | – | |
| – | – | – | -57.1% | +22.2% | -347.5% | – | -21.1% | -7,966.7% | – | – | – | |
| – | +76.7% | +16.6% | -32.9% | +12.1% | -57.4% | +64.5% | +60.5% | +60.8% | +67.1% | +37.1% | +69.0% | |
| – | +44.9% | +12.8% | -3.5% | +3.5% | -27.1% | +54.1% | +37.3% | +37.0% | +22.8% | +16.1% | +53.0% | |
| – | +60.9% | +23.1% | -29.4% | +19.5% | -78.8% | +289.2% | +51.3% | -50.8% | +22.8% | +16.1% | +627.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +24.0% | +38.6% | +15.7% | -100.0% | – | – | – | +63.6% | – | – | – | |
| – | – | – | – | -724.8% | – | – | – | – | – | – | – | |
| – | -31.3% | +58.9% | +16.3% | -46.6% | -294.2% | – | – | – | – | – | – | |
| – | – | – | – | -724.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.